GlassScriptPhysician profile
Mohamadamer Alaiti
NPI 1346445442
$71,954.84
in general payments reported to CMS, 2019-2025
29 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $8,973 · 2021: $12K · 2022: $15K · 2023: $3,172 · 2024: $5,746 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,025 · Consulting Fee: $4,600 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,600 · Travel and Lodging: $4,043 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,025.03 |
| Consulting Fee | $4,600.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,600.00 |
| Travel and Lodging | $4,042.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $48,138.41 | 2019-2025 | Dragonfly Opstar, Supera, Xience Skypoint |
| Abiomed | $11,850.39 | 2019-2024 | Impella |
| Edwards Lifesciences Corporation | $3,046.87 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $2,374.02 | 2022-2025 | Corevalve Evolut R |
| Inari Medical, INC. | $1,710.49 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $1,622.52 | 2019 | |
| Medtronic Vascular, INC. | $1,500.34 | 2019-2020 | |
| Shockwave Medical, INC | $283.67 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $187.19 | 2024-2025 | Epi-Ease Epicardial Access System, Atriclip Laa Exclusion System, Synergy Ablation System |
| Boston Scientific Corporation | $172.61 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Philips North America LLC | $142.50 | 2024 | (Bh4) Igt Devices Undivided |
| Stryker Corporation | $140.42 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.17 | 2024-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $73.13 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $67.76 | 2019-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $66.26 | 2024-2025 | Angiovac, Alphavac |
| Impulse Dynamics (USA) INC. | $59.62 | 2024-2025 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $58.15 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $57.86 | 2024-2025 | Camzyos |
| Bridgebio Pharma, INC. | $47.97 | 2025 | Attruby |
| Novo Nordisk INC | $45.28 | 2024-2025 | Ozempic |
| Teleflex LLC | $30.37 | 2023-2025 | Guideliner, Turnpike |
| Cvrx, INC. | $26.84 | 2024 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $23.00 | 2023 | Arcalyst |
| Pfizer INC. | $20.67 | 2023 | |
| Itamar Medical INC | $20.59 | 2023 | Watchpatone |
| Inspire Medical Systems, INC. | $17.91 | 2025 | Inspire |
| Recor Medical INC | $16.52 | 2024 | Paradise Renal Denervation System |
| Amgen INC. | $15.31 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamadamer Alaiti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.